Invest in ME Conference 12: First Class in Every Way
OverTheHills wraps up our series of articles on this year's 12th Invest in ME International Conference (IIMEC12) in London with some reflections on her experience as a patient attending the conference for the first time.
Discuss the article on the Forums.

Struggling Philadelphia biotech [Hemispherx] firm gets new CEO

Discussion in 'General ME/CFS News' started by Kati, Feb 27, 2016.

  1. Kati

    Kati Patient in training

    Messages:
    5,462
    Likes:
    19,549
    http://www.bizjournals.com/philadel...ngphiladelphia-biotech-firm-gets-new-ceo.html

    Exert:

    "The company is committed to a focused business plan oriented toward finding senior co-development partners with the capital and expertise needed to commercialize the many potential therapeutic aspects of our experimental drugs and our approved drug Alferon N. Management will make creating stockholder value and delivering much needed therapies to patients its prime objectives."
     
    CFS_for_19_years likes this.
  2. CFS_for_19_years

    CFS_for_19_years Hoarder of biscuits

    Messages:
    1,998
    Likes:
    5,040
    USA
    And in a related story:

    New Hemispherx (HEB) CEO Will Not Receive Salary for Two Months Until Stock Performs Better


    Read the rest of the story:
    http://www.biospace.com/News/new-hemispherx-ceo-will-not-receive-salary-for-two/412027
     
  3. Justin30

    Justin30 Senior Member

    Messages:
    1,065
    Likes:
    1,280
    Good for him, I respect that...this drug needs to make FDA approval and Dr Petterson and others need to define the patient cohort.
     

See more popular forum discussions.

Share This Page